PARP1 and Chagas disease: Furthermore, these researches showed short-term treatment with cGAS antagonists or PARP1 inhibitors was sufficient to potently suppress TEv-induced cytokines’ expression in macrophages, which offered a potential therapy for controlling Chagas disease (128).